# Chemotherapy in Treating Patients With Solid Tumors

> **NCT00003103** · PHASE1,PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 57 (estimated)

## Conditions studied

- Bladder Cancer
- Breast Cancer
- Colorectal Cancer
- Esophageal Cancer
- Head and Neck Cancer
- Kidney Cancer
- Lung Cancer
- Ovarian Cancer
- Prostate Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** oblimersen sodium
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00003103
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-08
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 57 (ESTIMATED)
- **Last updated:** 2013-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003103, "Chemotherapy in Treating Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00003103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*